PASG CIK: 1787297

Passage BIO, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−127
FY22:
−118
FY23:
−78.3
FY24:
−48.0
FY25:
−31.5
Change from FY21 to FY25
millions USD
FY21:
−45.8
FY22:
25.2
FY23:
65.2
FY24:
54.9
FY25:
40.2
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
−1.35
FY23:
0.14
FY24:
8.87
FY25:
0.02
millions USD
FY21:
−6.04
FY22:
−94.4
FY23:
−12.9
FY24:
15.9
FY25:
8.73
(positive)
Change from FY21 to FY24
millions USD
FY21:
−145
FY22:
−120
FY23:
−78.4
FY24:
−48.0
FY25:
–

All amounts in millions USD Data source:SEC EDGAR